Mark Bach
Hoofd Techniek/Wetenschap/O&O bij STRUCTURE THERAPEUTICS INC.
Vermogen: 56 126 $ op 30-04-2024
Actieve functies van Mark Bach
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2021 | - |
Loopbaan van Mark Bach
Eerdere bekende functies van Mark Bach
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Accumulus Synergy, Inc | Algemeen Directeur | 01-08-2019 | 01-10-2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01-11-2014 | 01-08-2019 |
Janssen Pharmaceutical KK
 Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals KK develops, manufactures, and markets prescription pharmaceutical products. The company was founded in 1978 and is located in Tokyo, Japan. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 | 01-11-2012 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-06-1993 | 01-01-2010 |
| ASCENDIS PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 | - |
Opleiding van Mark Bach
| Baylor College of Medicine | Doctorate Degree |
| The University of Chicago | Doctorate Degree |
| Carleton College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Denemarken | 2 |
| Japan | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| MERCK & CO., INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Bedrijven in privébezit | 3 |
|---|---|
| Accumulus Synergy, Inc | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals KK develops, manufactures, and markets prescription pharmaceutical products. The company was founded in 1978 and is located in Tokyo, Japan. | Health Technology |
